Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here
Sunday, July 17, 2011
Tainted-Blood Victims Not Told about Compensation Availability
Only recently, and a decade after the Canadian Red Cross Society put more than $70 million into a trust fund for people who received diseased blood transfusions, did the fund's trustee learn that no public notice was ever given about the availability of one portion of the fund.